Navigation Links
“Bridge” Protein Spurs Deadliest Stages of Breast Cancr

A protein known for its ability to “bridge” interactions between other cellular proteins may spur metastasis in breast cancer//, the disease’s deadliest stage, a study from Burnham Institute for Medical Research has found.

Led by professor Gen-Sheng Feng, Ph.D., and colleagues at Burnham and Royal Victoria Hospital in Montreal, Quebec, the study ranks among the first to more precisely define the cancer role for the protein known as Gab-2. These results, to be published in the journal Oncogene, have been made available to the worldwide medical research community by priority posting online at the journal’s website.

The protein has been of keen research interest for its role in breast cancer, but whether it controlled metastasis or initial tumor growth was unknown. Gab-2 is one of a group of proteins known as “scaffold” or “bridge” proteins, which provide a molecular intermediary to help cell signal proteins interact.

“Although Gab-2 is highly expressed in breast cancer, it is not essential for the development of cancer,” said Feng. “We found that Gab-2 is, however, essential for metastasis, or the spread of cancer. Breast cancer victims can survive before metastasis, but their chances decrease significantly when the cancer cells have spread. If we can understand precisely how Gab-2 functions in metastasis, then we might be able use this knowledge to design treatments that would block the deadly metastasis.”

Feng, who studies molecular signaling in embryonic stem cells and examines signaling pathways that are involved in obesity and diabetes, has studied the roles played by Gab-2 and its chemical cousin Gab-1, in various disorders. His fundamental analyses of cell signaling for Gab-2 led him to study the protein in cancer cells.

Feng and his colleagues began by examining Gab-2’s role in a pathway influenced by the cancer-causing oncogene Neu, which is implicated in nearly 30 percent of human breast cancers and
'"/>




Page: 1 2

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
4. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
5. Protein in urine foresees heart disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. Protein signals need for heart surgery
8. Protein and fat improve memory
9. Clotting Protein plays a role in nerve repair
10. High Levels of Protein Linked to Brain Shrinkage
11. Protein can change worn muscle fibres
Post Your Comments:
(Date:12/2/2008)...., Dec. 2 A number of recent publi...hood obesity, the health risks in,overweight chil...reals and,other foods kids consume. Yet one manu... natural, freeze-dried real fruit products that ar...provide most, if not all, of the daily fruit,serv...
(Date:12/2/2008)...hed Call to Action Highlights Need to Reduce Dispa...ational Efforts , , BETHESDA, Md., Dec. 2 ...tious Diseases, (NFID) S.T.O.P. (Share. Teach. O...ed of many of the nation,s leading medical and adv...ion to improve adolescent meningococcal vaccinatio...
(Date:12/2/2008)...ants can help keep driving safe, research shows ,...ivers talking on a cell phone are more distracted ... with a friend sitting next to them in the car, a ... process of joint attention, so when you have a pe...river, that person actually understands something ...
(Date:12/2/2008)...t Expands Leadership Team and Strengthens Commerci...wire/ -- BioNanomatrix, Inc., a developer of break...ics, personalized medicine and biomedical research... Ph.D., as vice president of business development....ess development experience with leading biotechnol...
Breaking Medicine News(10 mins):Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 2Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 3Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 2Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 3
...ould cut the risk of getting bowel cancer by more...ts do not recommend its continuous use due to poss...t tumors in the lower end of the gastro-intestinal...rs occur in the large intestine and 20 percent in ...
...ric name clopidogrel), the popular anti-blood-clot...ent recommended dose of Plavix to angioplasty pati... risk of heart attack and cardiac death by half. ...assistant professor of medicine at Virginia Common...
...essed over the housing together of two convicted p... Robbie Sebastian Wheeler, 43, and his boyfriend ...her in Hakea jail, in West Australia. The two men...ping a teenage boy and sexually molesting him for ...
... in children, according to a new study by a Housto...the survey studied the dietary intakes of 3,618 ch...t find a relationship between 100 percent juice co...among children," said Theresa Nicklas, a child nut...
Other Medicine News:Health News:Doubling Plavix Dose Recommended Before Angioplasty 2Health News:Outrage Against Gay PartnersInCrime Kept Together 2
(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/25/2008)...ewswire-FirstCall/ -- CardioVascular,BioTherapeut...day that it has,dosed the first patient in North ...al trial to treat patients with severe coronary he...tment of CORonary heart Disease) trial will includ...ed doses in approximately 120,patients with sever...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
(Date:11/24/2008)...Cancer Awareness Month , , Oak Brook, Ill.,...Society for Gastrointestinal Endoscopy (ASGE) and ...p this November to raise awareness about pancreati... the resources that are available for them. , ... of cancer deaths in the U.S. In 2008, an estimate...
Breaking Medicine Technology:Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 1AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 2AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 3AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 4Houston Heart Surgeon Elected Vice President of Guatemala 5534 1Houston Heart Surgeon Elected Vice President of Guatemala 5534 2Fragile X Foundations Sign Merger Agreement 5532 1Fragile X Foundations Sign Merger Agreement 5532 2Fragile X Foundations Sign Merger Agreement 5532 3Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 1Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 2
...d at the American College of,Cardiology,s Scientif...RNewswire-FirstCall/ -- CV,Therapeutics, Inc. anno...m the MERLIN TIMI-36 study of ranolazine shows the... patients on ranolazine.,The study did not meet th...the company,s special protocol assessment,agreemen...
...s Across the Genome From 242,Patients and Identifi...astic Leukemia, Suggesting New Targets for Improve...ire/ -- Investigators at,St. Jude Children,s Resea...d mutations that contribute to the formation of pe...st common cancer in,children. The discovery not on...
Other Medicine Technology:CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3Major Gene Study Uncovers Secrets of Leukemia 2Major Gene Study Uncovers Secrets of Leukemia 3
For the quantitative measurement of CKMB, Myoglobin, and Troponin-I in human serum.
According to the National Academy of Clinical Biochemistry guidelines for the use of cardiac markers in coronary artery disease, troponin I is definitive of acute myocardial infarction. The new Acces
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che
Clinical marker immunoassay kit for detection of Myoglobin.
Medicine Products: